The proceeds will support the company's development of CART-ddBCMA, a BCMA-specific CAR-modified T-cell therapy currently in Phase 1 and anticipated to begin a pivotal trial in 2022.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

25 West Watkins Mill Rd. A
Gaithersburg, MD 20878
USA

Phone

Undisclosed

Website

www.arcellx.com

Email Address

[email protected]

Overview

Arcellx is a privately held biopharmaceutical company located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rami Elghandour

Chief Financial Officer

Han Lee

Chief Medical Officer

Angela Shen

Chief Operating Officer

Michael Dombeck

Chief Technical Officer

David Hilbert

Vice President

Shashi Kaithamana

Vice President

Brian Murphy

VP - Bus. Development

Neeraj Teotia

VP - R & D

David Tice

VP - Regulatory Affairs

Brad Gliner

Browse more venture capital transactions:

Prev: 4/14/2021: Axiado venture capital transaction
Next: 4/14/2021: Transparent Health Marketplace venture capital transaction

Share this article

About Database of VC Transactions

We report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary